The IPO wave kept rolling for venture-capital-backed biotech as two life science companies held their first trading day Friday, while another estimated a price range for its public debut and a fourth publicly filed its paperwork.
Reuters Shares of Aquinox Pharmaceuticals Inc. rose 8.6%, while Recro Pharma Inc.‘s stock rose 3.8%.
Image: http://www.freedigitalphotos.net
To read the original article: Biotech IPO March Continues; Aquinox and Recro Rise - Venture Capital Dispatch - WSJ
